Pediatric Hematology and Oncology

Papers
(The H4-Index of Pediatric Hematology and Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity21
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas18
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study16
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial13
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India13
Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children13
Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia11
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas10
Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma10
COVID-19 reinfection in two children with cancer9
0.19774103164673